Alumni Ventures Group
Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, with offices across North America. It provides access to venture investing for individual accredited investors, particularly alumni networks, by offering diversified portfolios of venture opportunities and allowing members to invest alongside fellow alumni in ventures led by peers. The firm backs early-stage and later-stage opportunities across technology, consumer, healthcare, financial services, and other sectors, with a sector- and geography-agnostic approach. It typically invests between $10,000 and $3 million per deal and emphasizes the involvement of alumni connections and an institutional lead investor in opportunities. Alumni Ventures also offers focused funds to broaden participation, enabling accredited investors to access venture portfolios diversified by type, sector, stage, and geography. The model aims to democratize access to venture capital while maintaining rigorous selection standards through alumni networks.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Nanotechnology
Ion Storage Systems
Series A in 2024
Founded in 2015, Ion Storage Systems specializes in manufacturing solid-state lithium-ion batteries. The company serves the defense and aerospace, consumer electronics, and electric vehicles industries by developing energy-dense, safe, and non-flammable batteries using low-cost materials.
Bionaut Labs
Series B in 2024
Founded in 2016, Bionaut Labs specializes in developing intra-tissue navigation platforms using micro-robots for precise anatomical targeting. Its innovative technology enables remote-controlled delivery of therapeutics to challenging clinical settings, revolutionizing the treatment of central nervous system disorders and other diseases.
Nanochon
Seed Round in 2024
Nanochon is developing an implantable, 3D-printed cartilage implant designed to replace damaged cartilage and promote new tissue growth in joints, with a focus on knee damage. The device combines 3D printing and a novel nanomaterial to enable on-demand, cost-effective solutions intended to restore joint function and improve outcomes for young and active patients.
EeroQ
Seed Round in 2024
EeroQ is a company focused on designing quantum computer chips, specifically utilizing a novel approach that involves trapping and controlling individual electrons on superfluid helium. Founded to address the challenges in building large-scale quantum computers, EeroQ aims to advance the practical application of quantum technology through its innovative electron-on-helium architecture. This technology harnesses the purity of superfluid helium to preserve the intrinsic quantum properties of each electron, effectively creating qubits that enhance computing power delivery. Developed in collaboration with Michigan State University, EeroQ's core technology is protected by patents, positioning the company to lead advancements in the quantum computing field while also fostering discussions on ethical guidelines to ensure the technology's positive impact.
Solor
Pre Seed Round in 2024
SolOr is a supplier of techniques for creating integrated photovoltaic systems and paint based on nanomaterials. They offer photovoltaic technology, building-integrated photovoltaics technology, and quantum dots.
Ossium Health
Series C in 2023
Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.
Ion Storage Systems
Series A in 2023
Founded in 2015, Ion Storage Systems specializes in manufacturing solid-state lithium-ion batteries. The company serves the defense and aerospace, consumer electronics, and electric vehicles industries by developing energy-dense, safe, and non-flammable batteries using low-cost materials.
EeroQ
Seed Round in 2022
EeroQ is a company focused on designing quantum computer chips, specifically utilizing a novel approach that involves trapping and controlling individual electrons on superfluid helium. Founded to address the challenges in building large-scale quantum computers, EeroQ aims to advance the practical application of quantum technology through its innovative electron-on-helium architecture. This technology harnesses the purity of superfluid helium to preserve the intrinsic quantum properties of each electron, effectively creating qubits that enhance computing power delivery. Developed in collaboration with Michigan State University, EeroQ's core technology is protected by patents, positioning the company to lead advancements in the quantum computing field while also fostering discussions on ethical guidelines to ensure the technology's positive impact.
Nanopath
Series A in 2022
Nanopath is a molecular diagnostics company that develops innovative platforms for rapid disease diagnosis. Its technology enables point-of-care testing, eliminating the need for nucleic acid amplification and supporting multiplexed detection. This allows patients and healthcare providers to access accurate diagnostic results within standard office visits, improving healthcare outcomes.
Ion Storage Systems
Series A in 2022
Founded in 2015, Ion Storage Systems specializes in manufacturing solid-state lithium-ion batteries. The company serves the defense and aerospace, consumer electronics, and electric vehicles industries by developing energy-dense, safe, and non-flammable batteries using low-cost materials.
DUST Identity
Series B in 2021
DUST Identity, Inc. specializes in developing advanced authentication technology that employs nano-diamonds to create an unclonable identity layer on various objects within supply chains. Founded in 2011 and headquartered in Framingham, Massachusetts, with an additional office in Princeton, New Jersey, the company offers a proprietary system known as DUST, which includes an optical scanner and a cloud-based infrastructure. This system provides an interface for managing object identity and provenance, ensuring that products can be verified and trusted throughout their lifecycle. By linking physical items to their digital records, DUST Identity enables businesses to access critical data regarding product sourcing, testing, and certification, thereby enhancing safety and traceability across their value chains.
Sepion Technologies
Series A in 2021
Sepion Technologies is an advanced membrane company based in Emeryville, California, founded in 2015. It specializes in the development of highly-tunable nanoscale membranes designed for various industrial applications, particularly in the energy storage sector. The company focuses on manufacturing innovative lithium-metal batteries by integrating nanoscience, polymer chemistry, and cell engineering. Its proprietary composite membrane serves as a cost-effective alternative to traditional ceramic separators used in lithium batteries, allowing for large-area production. This technology enables battery manufacturers to enhance energy density in their products, thereby improving overall performance and efficiency in energy storage solutions.
Ionobell
Seed Round in 2020
Ionobell is a battery technology developer specializing in improving battery longevity and performance using eco-friendly materials. They focus on utilizing biomaterials, plastic waste, and recycled materials to create safe, abundant, and cost-effective batteries for electric vehicles and unmanned aerial vehicles.
Celularity
Venture Round in 2017
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies targeting various diseases, including cancer, infectious, and degenerative conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.